There was no revenue recorded for the fourth quarter or full year ended December 31, 2024, compared to $1.0 million in the year ended December 31, 2023. Revenue in 2023 was related to a milestone ...
Spring officially starts March 20, but we're already in allergy season. Let's talk about the signs, symptoms, treatments, and ...
KHQA on MSN15h
Blessing Health introduces new FDA-approved nasal spray treatment for resistant depressionUp to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...
Chronic rhinosinusitis with nasal polyps presents a substantial clinical burden, affecting nasal airflow, olfactory function, ...
16h
"Dry throat tissues can increase snoring, so drinking enough water throughout the day should help combat this," he recommends ...
Neffy (epinephrine nasal spray) 1mg is approved for the emergency treatment of type 1 allergic reactions in children aged 4 ...
Nasal anti-CD3 spray reduces traumatic brain injury in mice, a potential breakthrough for TBI treatment. Read now.
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...
5don MSN
Shares of the company were up 5.2% in extended trading. The spray, sold under the brand name neffy, will be dosed at 1 ...
The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...
Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback